医薬品有効成分の市場規模、シェア、動向分析レポート：合成タイプ別、メーカー別、タイプ別、用途別、地域別、セグメント予測、2025年～2030年

医薬品有効成分市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の医薬品有効成分市場規模は2030年までに3,594億5,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 5.85％で成長すると予測されています。この市場を牽引するのは、バイオ医薬品セグメントの成長、医薬品有効成分（API）製造の進歩、高齢者の増加です。

キャプティブAPIセグメントの成長は、企業がAPI内製化のための課題解決や新しい化学的方法の開発に投資することによって推進されます。これはコストと汚染リスクの削減に役立ちます。人工知能とタンパク質合成は、プロセスの制御性を高め、より迅速な開発を促進すると期待されています。

心血管疾患などの慢性疾患やライフスタイルによる疾患の有病率の上昇は、APIの需要を加速させています。例えば、2020年の米国薬剤師によると、成人の47％が心血管疾患の開発を支える危険因子を少なくとも1つ持っています。心血管疾患は、世界の公衆衛生上の重大な負担の一つであり、このセグメントにおける医薬品有効成分の広範な研究開発を推進しています。

医薬品有効成分市場は、COVID-19のパンデミックから好影響を受け、COVID-19の治療需要を満たすために、各国や主要企業が大量の成分を生産しています。大流行の結果、製薬会社はより多くの患者集団に焦点を当てるよう戦略を変更しました。コロナウイルスを治療するため、例えば米国はHCQをインドから輸入するよう要請しました。このウイルスはカナダの医薬品供給システムにも影響を与え、患者に合併症を引き起こす可能性があります。ジェネリック医薬品の重要性の高まり、バイオ医薬品消費の増加、医薬品製造のための研究開発活動の拡大が、市場成長の1次促進要因です。しかし、市場の拡大は、いくつかの国における不利な薬価規制と高い製造コストによって阻害される可能性が高いです。

インドのような新興国は、地政学的な状況により、中国のようなAPI市場の支配的な国々よりも市場で選好されています。さらに、インドには高品質の原料や製品、大規模な労働力、広大な流通網、「Make in India」プログラムによる政府補助金があります。

アンメット・メディカル・ニーズに対応するため、企業は共同で新規治療法を開発しています。これによって、企業は自社のリソースを製品開発の支援やサプライチェーンの強化に活用することができます。2021年11月、Merck &Co Inc.はAcceleron Pharmaを買収したと発表しました。この買収はMerck &Coの心血管ポートフォリオとパイプラインの拡大に役立つと考えられます。

医薬品有効成分市場レポートハイライト

• 新薬開発のための研究開発活動の活発化と政府の積極的な取り組みにより、2024年には革新的APIが62.0%の最大シェアを占めました。
• キャプティブAPIセグメントは2024年に51.03%の最大シェアを占めました。
• 合成APIセグメントは、2024年に70.66%の最大収益シェアで市場を独占したが、これは原料の入手可能性が高く、これらの分子の合成プロトコールが容易なためです。
• 北米は2024年に38.26%の最大収益シェアを占め、予測期間中もそのリードを維持すると予測されています。これは、他の生活習慣病とともにがんの疫学が上昇しているため、研究開発活動が促進され、市場の成長を後押ししているためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品有効成分市場：市場変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の展望
• 市場力学
• 市場促進要因
• 市場抑制要因分析
• ビジネス環境分析

第4章 医薬品有効成分市場：合成タイプ別、推定・動向分析

• セグメントダッシュボード
• 医薬品有効成分市場：合成タイプ変動分析
• 医薬品有効成分市場合成タイプ別展望
• 2018～2030年の市場規模と予測と動向分析
• バイオティックAPI
  • バイオティックAPI市場、2018～2030年
• 合成API
  • 合成API市場、2018～2030年

第5章 医薬品有効成分市場：メーカータイプ別、推定・動向分析

• セグメントダッシュボード
• 医薬品有効成分市場：メーカータイプ変動分析
• 医薬品有効成分市場メーカータイプ別展望
• 2018～2030年の市場規模と予測と動向分析
• キャプティブAPI
  • キャプティブAPI市場、2018～2030年
• マーチャントAPI
  • マーチャントAPI市場、2018～2030年

第6章 医薬品有効成分市場：タイプ別、推定・動向分析

• セグメントダッシュボード
• 医薬品有効成分市場：タイプ変動分析
• 医薬品有効成分市場タイプ別展望
• 2018～2030年の市場規模と予測と動向分析
• 汎用API
  • ジェネリック API市場、2018～2030年
• 革新的なAPI
  • 革新的なAPI市場、2018～2030年

第7章 医薬品有効成分市場：用途別、推定・動向分析

• セグメントダッシュボード
• 医薬品有効成分市場：用途変動分析
• 用途別医薬品有効成分市場展望
• 2018～2030年の市場規模と予測と動向分析
• 心血管疾患
  • 心血管疾患市場、2018～2030年
• 腫瘍学
  • 腫瘍学市場、2018～2030年
• 中枢神経系と神経学
  • 中枢神経系と神経学市場、2018～2030年
• 整形外科
  • 整形外科市場、2018～2030年
• 内分泌学
  • 内分泌学市場、2018～2030年
• 呼吸器科
  • 呼吸器科市場、2018～2030年
• 消化器内科
  • 消化器内科市場、2018～2030年
• 腎臓病
  • 腎臓病市場、2018～2030年
• 眼科
  • 眼科市場、2018～2030年
• その他
  • その他市場、2018～2030年

第8章 医薬品有効成分市場：医薬品タイプ別、推定・動向分析

• セグメントダッシュボード
• 医薬品有効成分市場：医薬品タイプ変動分析
• 医薬品タイプ別医薬品有効成分市場展望
• 2018～2030年の市場規模と予測と動向分析
• 処方箋
  • 処方薬市場、2018～2030年
• 市販薬
  • 市販薬市場、2018～2030年

第9章 医薬品有効成分市場：地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 北米の医薬品有効成分市場、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の医薬品有効成分市場、2018～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の医薬品有効成分市場、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカ医薬品有効成分市場、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ医薬品有効成分市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 参入企業概要
• 参入企業
  • マーケットリーダー
  • 医薬品有効成分市場シェア分析、2024年
  • 企業プロファイル

List of Tables

• Table 1 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
• Table 2 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 3 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 4 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 5 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 6 Global Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 7 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
• Table 8 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 9 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 10 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 11 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 12 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 13 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 15 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 16 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 17 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 22 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 23 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 24 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 25 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 26 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 27 Mexico Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 28 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
• Table 29 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 30 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 31 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 32 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 33 Europe Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 34 UK Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 35 UK Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 36 UK Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 37 UK Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 38 UK Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 39 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 40 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 41 Germany Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 42 Germany Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 43 Germany Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 44 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 45 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 46 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 47 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 48 France Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 49 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 50 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 51 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 52 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 53 Italy Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 54 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 55 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 56 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 57 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 58 Spain Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 59 Denmark Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 60 Denmark Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 61 Denmark Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 62 Denmark Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 63 Denmark Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 64 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 65 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 66 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 67 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 68 Sweden Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 69 Norway Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 70 Norway Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 71 Norway Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 72 Norway Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 73 Norway Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 74 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
• Table 75 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 76 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 77 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 78 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 79 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 80 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 81 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 82 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 83 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 84 Japan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 85 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 86 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 87 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 88 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 89 China Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 90 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 91 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 92 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 93 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 94 India Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 95 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 96 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 97 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 98 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 99 Australia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 100 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 101 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 102 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 103 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 104 South Korea Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 105 Thailand Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 106 Thailand Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 107 Thailand Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 108 Thailand Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 109 Thailand Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 110 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
• Table 111 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 112 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 113 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 114 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 115 Latin America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 116 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 117 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 118 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 119 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 120 Brazil Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 121 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 122 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 123 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 124 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 125 Argentina Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 126 Middle East & Africa Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
• Table 127 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 128 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 129 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 130 Middle East & Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 131 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 132 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 133 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 134 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 135 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 136 South Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 137 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 138 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 139 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 140 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 141 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 142 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 143 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 144 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 145 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 146 UAE Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
• Table 147 Kuwait Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
• Table 148 Kuwait Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
• Table 149 Kuwait Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
• Table 150 Kuwait Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
• Table 151 Kuwait Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Primary research pattern
• Fig. 3 Market research approaches
• Fig. 4 Value chain-based sizing & forecasting
• Fig. 5 Market formulation & validation
• Fig. 6 API Market market segmentation
• Fig. 7 Market driver analysis (current & future impact)
• Fig. 8 Market restraint analysis (current & future impact)
• Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 10 Porter's five forces analysis
• Fig. 11 Active pharmaceutical ingredients market: Type of synthesis movement analysis
• Fig. 12 Biotech APIs market, 2018 - 2030 (USD Billion)
• Fig. 13 Synthetic APIs market, 2018 - 2030 (USD Billion)
• Fig. 14 Active pharmaceutical ingredients market: Type of manufacturer movement analysis
• Fig. 15 Captive APIs market, 2018 - 2030 (USD Billion)
• Fig. 16 Merchant APIs market, 2018 - 2030 (USD Billion)
• Fig. 17 Active pharmaceutical ingredients market: Type movement analysis
• Fig. 18 Generic APIs market, 2018 - 2030 (USD Billion)
• Fig. 19 Innovative APIs market, 2018 - 2030 (USD Billion)
• Fig. 20 Active pharmaceutical ingredients market: Application movement analysis
• Fig. 21 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
• Fig. 22 Oncology market, 2018 - 2030 (USD Billion)
• Fig. 23 CNS and Neurology market, 2018 - 2030 (USD Billion)
• Fig. 24 Orthopaedic market, 2018 - 2030 (USD Billion)
• Fig. 25 Endocrinology market, 2018 - 2030 (USD Billion)
• Fig. 26 Pulmonology market, 2018 - 2030 (USD Billion)
• Fig. 27 Gastroenterology market, 2018 - 2030 (USD Billion)
• Fig. 28 Nephrology market, 2018 - 2030 (USD Billion)
• Fig. 29 Ophthalmology market, 2018 - 2030 (USD Billion)
• Fig. 30 Others market, 2018 - 2030 (USD Billion)
• Fig. 31 Active pharmaceutical ingredients market: Type of drug movement analysis
• Fig. 32 Prescription market, 2018 - 2030 (USD Billion)
• Fig. 33 OTC market, 2018 - 2030 (USD Billion)
• Fig. 34 North America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 35 U.S. active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 36 Canada active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 37 Mexico active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 38 Europe active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 39 UK active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 40 Germany active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 41 Italy active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 42 Spain active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 43 France active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 44 Denmark active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 45 Sweden active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 46 Norway active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 47 Asia Pacific active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 48 Japan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 49 China active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 50 India active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 51 Australia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 52 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 53 South Korea active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 54 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 55 Latin America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 56 Brazil active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 57 Argentina active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 58 MEA active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 59 South Africa active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 60 Saudi Arabia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 61 UAE active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• Fig. 62 Kuwait active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)

Active Pharmaceutical Ingredients Market Growth & Trends:

The global active pharmaceutical ingredients market size is anticipated to reach USD 359.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.85% from 2025 to 2030. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical Ingredients (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in-house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The active pharmaceutical Ingredients market was positively influenced by the COVID-19 pandemic, as countries and significant players produce large quantities of components to meet the demand for the treatment of COVID-19. As a result of the outbreak, drug companies have changed the companies' strategies to focus on a larger patient population. To treat coronavirus, the U.S., for example, requested that HCQ be imported from India. The virus has also impacted Canada's medicine supply system, potentially causing complications for patients. The increasing importance of generics, rise in consumption of biopharmaceuticals, and expanding drug research and development activities for drug manufacturing are the primary drivers driving the growth of the market. However, the market's expansion is likely to be hampered by unfavorable drug price control regimes in several countries and high manufacturing costs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, India has quality raw materials and products, a large workforce, a vast distribution network, and government subsidies through the "Make in India" program.

To address unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In November 2021, Merck & Co Inc. announced that it has acquired Acceleron Pharma, this acquisition would help Merck & Co to expand their cardiovascular portfolio and pipeline.

Active Pharmaceutical Ingredients Market Report Highlights:

• Innovative APIs held the largest share of 62.0% in 2024, owing to increasing research and development activities for novel drug development and positive government initiatives
• Captive APIs segment held the largest market share of 51.03% in 2024
• The synthetic API segment dominated the market with the largest revenue share of 70.66% in 2024, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules
• North America accounted for the largest revenue share of 38.26% in 2024 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Market Definitions
• 1.2. Objectives
  • 1.2.1. Objective - 1
  • 1.2.2. Objective - 2
  • 1.2.3. Objective - 3
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Active Pharmaceutical Ingredients Market: Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers
  • 3.4.1. Increasing geriatric population
  • 3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
  • 3.4.3. Increasing preference for targeted therapy approach in cancer treatment
  • 3.4.4. Increasing preference for outsourcing APIs
• 3.5. Market Restraint Analysis
  • 3.5.1. High capital investments and production cost
  • 3.5.2. Stringent Safety and handling regulations regarding APIs
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Active Pharmaceutical Ingredients Market: Type of Synthesis Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
• 4.3. Active Pharmaceutical Ingredients Market by Type of Synthesis Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Biotic APIs
  • 4.5.1. Biotic APIs Market, 2018 - 2030 (USD Billion)
    • 4.5.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
    • 4.5.1.2. Generic APIs
      • 4.5.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
    • 4.5.1.3. Innovative APIs
      • 4.5.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
    • 4.5.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
    • 4.5.1.5. Monoclonal Antibodies
      • 4.5.1.5.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
    • 4.5.1.6. Hormones
      • 4.5.1.6.1. Hormones Market, 2018 - 2030 (USD Billion)
    • 4.5.1.7. Cytokines
      • 4.5.1.7.1. Cytokines Market, 2018 - 2030 (USD Billion)
    • 4.5.1.8. Recombinant Proteins
      • 4.5.1.8.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
    • 4.5.1.9. Therapeutic Enzymes
      • 4.5.1.9.1. Therapeutic Enzymes Market, 2018 - 2030 (USD Billion)
    • 4.5.1.10. Vaccines
      • 4.5.1.10.1. Vaccines Market, 2018 - 2030 (USD Billion)
    • 4.5.1.11. Blood Factors
      • 4.5.1.11.1. Blood Factors Market, 2018 - 2030 (USD Billion)
• 4.6. Synthetic APIs
  • 4.6.1. Synthetic APIs Market, 2018 - 2030 (USD Billion)
    • 4.6.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
    • 4.6.1.2. Generic APIs
      • 4.6.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
    • 4.6.1.3. Innovative APIs
      • 4.6.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 5. Active Pharmaceutical Ingredients Market: Type of Manufacturer Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Active Pharmaceutical Ingredients Market: Type Movement Analysis
• 5.3. Active Pharmaceutical Ingredients Market by Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Captive APIs
  • 5.5.1. Captive APIs Market, 2018 - 2030 (USD Billion)
• 5.6. Merchant APIs
  • 5.6.1. Merchant APIs Market, 2018 - 2030 (USD Billion)

Chapter 6. Active Pharmaceutical Ingredients Market: Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Active Pharmaceutical Ingredients Market: Type Movement Analysis
• 6.3. Active Pharmaceutical Ingredients Market by Type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Generic APIs
  • 6.5.1. Generic APIs Market, 2018 - 2030 (USD Billion)
• 6.6. Innovative APIs
  • 6.6.1. Innovative APIs Market, 2018 - 2030 (USD Billion)

Chapter 7. Active Pharmaceutical Ingredients Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Active Pharmaceutical Ingredients Market: Application Movement Analysis
• 7.3. Active Pharmaceutical Ingredients Market by Application Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Cardiovascular Diseases
  • 7.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
• 7.6. Oncology
  • 7.6.1. Innovative APIs Oncology Market, 2018 - 2030 (USD Billion)
• 7.7. CNS and Neurology
  • 7.7.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
• 7.8. Orthopedic
  • 7.8.1. Orthopedic Market, 2018 - 2030 (USD Billion)
• 7.9. Endocrinology
  • 7.9.1. Endocrinology Market, 2018 - 2030 (USD Billion)
• 7.10. Pulmonology
  • 7.10.1. Pulmonology Market, 2018 - 2030 (USD Billion)
• 7.11. Gastroenterology
  • 7.11.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
• 7.12. Nephrology
  • 7.12.1. Nephrology Market, 2018 - 2030 (USD Billion)
• 7.13. Ophthalmology
  • 7.13.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
• 7.14. Others
  • 7.14.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 8. Active Pharmaceutical Ingredients Market: Type of Drug Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
• 8.3. Active Pharmaceutical Ingredients Market by Type of Drug Outlook (USD Million)
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. Prescription
  • 8.5.1. Prescription Market, 2018 - 2030 (USD Billion)
• 8.6. OTC
  • 8.6.1. OTC Market, 2018 - 2030 (USD Billion)

Chapter 9. Active Pharmaceutical Ingredients Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. North America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Target Disease Prevalence
    • 9.3.2.3. Competitive Scenario
    • 9.3.2.4. Regulatory Framework
    • 9.3.2.5. Reimbursement Scenario
    • 9.3.2.6. U.S. Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Target Disease Prevalence
    • 9.3.3.3. Competitive Scenario
    • 9.3.3.4. Regulatory Framework
    • 9.3.3.5. Reimbursement Scenario
    • 9.3.3.6. Canada Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Target Disease Prevalence
    • 9.3.4.3. Competitive Scenario
    • 9.3.4.4. Regulatory Framework
    • 9.3.4.5. Reimbursement Scenario
    • 9.3.4.6. Mexico Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• 9.4. Europe
  • 9.4.1. Europe Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.2. Germany
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Target Disease Prevalence
    • 9.4.2.3. Competitive Scenario
    • 9.4.2.4. Regulatory Framework
    • 9.4.2.5. Reimbursement Scenario
    • 9.4.2.6. Germany Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.3. UK
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Target Disease Prevalence
    • 9.4.3.3. Competitive Scenario
    • 9.4.3.4. Regulatory Framework
    • 9.4.3.5. Reimbursement Scenario
    • 9.4.3.6. UK Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Target Disease Prevalence
    • 9.4.4.3. Competitive Scenario
    • 9.4.4.4. Regulatory Framework
    • 9.4.4.5. Reimbursement Scenario
    • 9.4.4.6. France Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Target Disease Prevalence
    • 9.4.5.3. Competitive Scenario
    • 9.4.5.4. Regulatory Framework
    • 9.4.5.5. Reimbursement Scenario
    • 9.4.5.6. Italy Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Target Disease Prevalence
    • 9.4.6.3. Competitive Scenario
    • 9.4.6.4. Regulatory Framework
    • 9.4.6.5. Reimbursement Scenario
    • 9.4.6.6. Spain Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Target Disease Prevalence
    • 9.4.7.3. Competitive Scenario
    • 9.4.7.4. Regulatory Framework
    • 9.4.7.5. Reimbursement Scenario
    • 9.4.7.6. Denmark Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Target Disease Prevalence
    • 9.4.8.3. Competitive Scenario
    • 9.4.8.4. Regulatory Framework
    • 9.4.8.5. Reimbursement Scenario
    • 9.4.8.6. Sweden Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Target Disease Prevalence
    • 9.4.9.3. Competitive Scenario
    • 9.4.9.4. Regulatory Framework
    • 9.4.9.5. Reimbursement Scenario
    • 9.4.9.6. Norway Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Target Disease Prevalence
    • 9.5.2.3. Competitive Scenario
    • 9.5.2.4. Regulatory Framework
    • 9.5.2.5. Reimbursement Scenario
    • 9.5.2.6. Japan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Target Disease Prevalence
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Regulatory Framework
    • 9.5.3.5. Reimbursement Scenario
    • 9.5.3.6. China Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Target Disease Prevalence
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. Regulatory Framework
    • 9.5.4.5. Reimbursement Scenario
    • 9.5.4.6. India Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Target Disease Prevalence
    • 9.5.5.3. Competitive Scenario
    • 9.5.5.4. Regulatory Framework
    • 9.5.5.5. Reimbursement Scenario
    • 9.5.5.6. South Korea Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Target Disease Prevalence
    • 9.5.6.3. Competitive Scenario
    • 9.5.6.4. Regulatory Framework
    • 9.5.6.5. Reimbursement Scenario
    • 9.5.6.6. Australia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Target Disease Prevalence
    • 9.5.7.3. Competitive Scenario
    • 9.5.7.4. Regulatory Framework
    • 9.5.7.5. Reimbursement Scenario
    • 9.5.7.6. Thailand Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• 9.6. Latin America
  • 9.6.1. Latin America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Target Disease Prevalence
    • 9.6.2.3. Competitive Scenario
    • 9.6.2.4. Regulatory Framework
    • 9.6.2.5. Reimbursement Scenario
    • 9.6.2.6. Brazil Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Target Disease Prevalence
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Regulatory Framework
    • 9.6.3.5. Reimbursement Scenario
    • 9.6.3.6. Argentina Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
• 9.7. MEA
  • 9.7.1. MEA Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Target Disease Prevalence
    • 9.7.2.3. Competitive Scenario
    • 9.7.2.4. Regulatory Framework
    • 9.7.2.5. Reimbursement Scenario
    • 9.7.2.6. South Africa Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Target Disease Prevalence
    • 9.7.3.3. Competitive Scenario
    • 9.7.3.4. Regulatory Framework
    • 9.7.3.5. Reimbursement Scenario
    • 9.7.3.6. Saudi Arabia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Target Disease Prevalence
    • 9.7.4.3. Competitive Scenario
    • 9.7.4.4. Regulatory Framework
    • 9.7.4.5. Reimbursement Scenario
    • 9.7.4.6. UAE Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Target Disease Prevalence
    • 9.7.5.3. Competitive Scenario
    • 9.7.5.4. Regulatory Framework
    • 9.7.5.5. Reimbursement Scenario
    • 9.7.5.6. Kuwait Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)

Chapter 10. Competitive Landscape

• 10.1. Participant's overview
• 10.2. Financial performance
• 10.3. Participant categorization
  • 10.3.1. Market Leaders
  • 10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2024
  • 10.3.3. Company Profiles
    • 10.3.3.1. Dr. Reddy's Laboratories Ltd.
      • 10.3.3.1.1. Company Overview
      • 10.3.3.1.2. Financial Performance
      • 10.3.3.1.3. Product Benchmarking
      • 10.3.3.1.4. Strategic Initiatives
    • 10.3.3.2. Sun Pharmaceutical Industries Ltd.
      • 10.3.3.2.1. Company Overview
      • 10.3.3.2.2. Financial Performance
      • 10.3.3.2.3. Product Benchmarking
      • 10.3.3.2.4. Strategic Initiatives
    • 10.3.3.3. Teva Pharmaceutical Industries Ltd.
      • 10.3.3.3.1. Company Overview
      • 10.3.3.3.2. Financial Performance
      • 10.3.3.3.3. Product Benchmarking
      • 10.3.3.3.4. Strategic Initiatives
    • 10.3.3.4. Cipla Inc.
      • 10.3.3.4.1. Company Overview
      • 10.3.3.4.2. Financial Performance
      • 10.3.3.4.3. Product Benchmarking
      • 10.3.3.4.4. Strategic Initiatives
    • 10.3.3.5. AbbVie Inc.
      • 10.3.3.5.1. Company Overview
      • 10.3.3.5.2. Financial Performance
      • 10.3.3.5.3. Product Benchmarking
      • 10.3.3.5.4. Strategic Initiatives
    • 10.3.3.6. Aurobindo Pharma
      • 10.3.3.6.1. Company Overview
      • 10.3.3.6.2. Financial Performance
      • 10.3.3.6.3. Product Benchmarking
      • 10.3.3.6.4. Strategic Initiatives
    • 10.3.3.7. Sandoz International GmbH (Novartis AG)
      • 10.3.3.7.1. Company Overview
      • 10.3.3.7.2. Financial Performance
      • 10.3.3.7.3. Product Benchmarking
      • 10.3.3.7.4. Strategic Initiatives
    • 10.3.3.8. Viatris Inc.
      • 10.3.3.8.1. Company Overview
      • 10.3.3.8.2. Financial Performance
      • 10.3.3.8.3. Product Benchmarking
      • 10.3.3.8.4. Strategic Initiatives
    • 10.3.3.9. Fresenius Kabi AG
      • 10.3.3.9.1. Company Overview
      • 10.3.3.9.2. Financial Performance
      • 10.3.3.9.3. Product Benchmarking
      • 10.3.3.9.4. Strategic Initiatives
    • 10.3.3.10. STADA Arzneimittel AG
      • 10.3.3.10.1. Company Overview
      • 10.3.3.10.2. Financial Performance
      • 10.3.3.10.3. Product Benchmarking
      • 10.3.3.10.4. Strategic Initiatives